Aarey Drugs & Pharmaceuticals Share Price
Start SIP in Aarey Drugs & Pharmaceuticals
Start SIPAarey Drugs & Pharmaceuticals Performance
Day Range
- Low 65
- High 68
52 Week Range
- Low 37
- High 75
- Open Price68
- Previous Close68
- Volume30012
Aarey Drugs & Pharmaceuticals Investment Rating
-
Master Rating:
-
Aarey Drugs & Pharms. has an operating revenue of Rs. 471.57 Cr. on a trailing 12-month basis. An annual revenue de-growth of -5% needs improvement, Pre-tax margin of 1% needs improvement, ROE of 3% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 11% and 32% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 1% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 80 which is a GOOD score indicating consistency in earnings, a RS Rating of 69 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 48 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of B is close to being the best. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
| Indicator | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|---|---|---|
| Oper Rev Qtr Cr | 127 | 210 | 76 | 58 | 51 | 158 |
| Operating Expenses Qtr Cr | 126 | 212 | 74 | 56 | 50 | 160 |
| Operating Profit Qtr Cr | 1 | -1 | 3 | 2 | 1 | -2 |
| Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Qtr Cr | 1 | 1 | 1 | 1 | 1 | 1 |
| Tax Qtr Cr | 0 | 0 | 0 | 0 | 0 | 2 |
| Net Profit Qtr Cr | 1 | 2 | 1 | 1 | 1 | 0 |
Aarey Drugs & Pharmaceuticals Technicals
EMA & SMA
- Bullish Moving Average
- ___
- 7
- Bearish Moving Average
- ___
- 9
- 20 Day
- ₹68.01
- 50 Day
- ₹63.71
- 100 Day
- ₹58.67
- 200 Day
- ₹53.66
- 20 Day
- ₹68.77
- 50 Day
- ₹62.70
- 100 Day
- ₹55.59
- 200 Day
- ₹52.72
Aarey Drugs & Pharmaceuticals Resistance and Support
| Resistance | |
|---|---|
| First Resistance | 68.08 |
| Second Resistance | 69.91 |
| Third Resistance | 71.67 |
| RSI | 47.42 |
| MFI | 53.88 |
| MACD Single Line | 1.87 |
| MACD | 1.21 |
| Support | |
|---|---|
| First Support | 64.49 |
| Second Support | 62.73 |
| Third Supoort | 60.90 |
Aarey Drugs & Pharmaceuticals Delivery and Volume
| Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
|---|---|---|---|
| Day | 33,493 | 3,349,300 | 100 |
| Week | 48,079 | 4,807,900 | 100 |
| 1 Month | 64,432 | 6,443,200 | 100 |
| 6 Month | 107,559 | 7,705,549 | 71.64 |
Aarey Drugs & Pharmaceuticals Result Highlights
Aarey Drugs & Pharmaceuticals Synopsis
NSE-Medical-Diversified
Aarey Drugs & Ph is involved in the business activities of Activities of commission agents dealing in wholesale trade inwood, paper, skin, leather and fur, fuel, petroleum products, chemicals, perfumery and cosmetics, glass, minerals, ores and metals. Company’s Total Operating Revenue is Rs. 418.96 Cr. and Equity Capital is Rs. 25.38 Cr. for the Year ended 31/03/2023. Aarey Drugs & Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/05/1990 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L99999MH1990PLC056538 and registration number is 056538.| Market Cap | 190 |
| Sales | 472 |
| Shares in Float | 1.54 |
| No of funds | 1 |
| Yield | 0.44 |
| Book Value | 1.43 |
| U/D Vol ratio | 2 |
| LTDebt / Equity | 2 |
| Alpha | 0.09 |
| Beta | 0.81 |
Aarey Drugs & Pharmaceuticals Shareholding Pattern
| Owner Name | Jun-24 | Mar-24 | Dec-23 | Sep-23 |
|---|---|---|---|---|
| Promoters | 45.28% | 45.28% | 50.04% | 50.04% |
| Foreign Portfolio Investors | 3.4% | 3.4% | 3.83% | 3.94% |
| Individual Investors | 44.5% | 47.14% | 41.14% | 40.61% |
| Others | 6.82% | 4.18% | 4.99% | 5.41% |
Aarey Drugs & Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Mihir R Ghatalia | Chairman & Managing Director |
| Mr. Nimit Rajesh Ghatalia | Executive Director |
| Ms. Archana Pramod Wani | Woman Director |
| Mr. Lalit Radhakrishna Tulsiani | Independent Director |
| Mr. Anil Mandal | Independent Director |
| Mr. Chetan K Mehta | Independent Director |
Aarey Drugs & Pharmaceuticals Forecast
Price Estimates
Aarey Drugs & Pharmaceuticals Corporate Action
| Date | Purpose | Remarks |
|---|---|---|
| 2024-10-01 | Others | |
| 2024-08-14 | Quarterly Results | |
| 2024-05-30 | Audited Results | |
| 2024-03-27 | Others | Inter alia, to consider the allotment of Equity Shares and Warrants. |
| 2024-02-14 | Quarterly Results |
Aarey Drugs & Pharmaceuticals FAQs
What is Share Price of Aarey Drugs & Pharmaceuticals ?
Aarey Drugs & Pharmaceuticals share price is ₹66 As on 04 October, 2024 | 22:34
What is the Market Cap of Aarey Drugs & Pharmaceuticals ?
The Market Cap of Aarey Drugs & Pharmaceuticals is ₹185.9 Cr As on 04 October, 2024 | 22:34
What is the P/E ratio of Aarey Drugs & Pharmaceuticals ?
The P/E ratio of Aarey Drugs & Pharmaceuticals is 35.8 As on 04 October, 2024 | 22:34
What is the PB ratio of Aarey Drugs & Pharmaceuticals ?
The PB ratio of Aarey Drugs & Pharmaceuticals is 1.4 As on 04 October, 2024 | 22:34